Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Haemonetics Corp (NY: HAE ) 75.63 +0.55 (+0.73%) Streaming Delayed Price Updated: 2:15 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Haemonetics Corp < Previous 1 2 3 4 Next > Incyte, Haemonetics Post Earnings Beats; One Surges Within Buy Zone February 07, 2023 Haemonetics stock rose within a buy zone on Tuesday, but Incyte stock toppled. Via Investor's Business Daily Earnings Preview: Haemonetics February 06, 2023 Via Benzinga Where Haemonetics Stands With Analysts January 24, 2023 Via Benzinga How 2022's Biggest Healthcare Gainers Could Fare In 2023 January 06, 2023 Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023 Via MarketBeat 9 Analysts Have This to Say About Haemonetics December 12, 2022 Via Benzinga InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold November 16, 2022 The Relative Strength (RS) Rating for InMode stock moved up into a higher percentile Wednesday, as it got a lift from 64 to 78. Via Investor's Business Daily Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As Catalyst November 08, 2022 Via Benzinga Watch for Continued Gains in Shares of Haemonetics Corporation (HAE) September 12, 2022 Via Investor Brand Network Where Haemonetics Stands With Analysts August 11, 2022 Within the last quarter, Haemonetics (NYSE:HAE) has observed the following analyst ratings: Via Benzinga Haemonetics: Q1 Earnings Insights August 10, 2022 Haemonetics (NYSE:HAE) reported its Q1 earnings results on Wednesday, August 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Stocks That Hit 52-Week Lows On Thursday December 01, 2022 During Thursday's session, 108 stocks hit new 52-week highs. Via Benzinga Haemonetics: Q2 Earnings Insights November 07, 2022 Haemonetics (NYSE:HAE) reported its Q2 earnings results on Monday, November 7, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Haemonetics beat estimated earnings... Via Benzinga Expert Ratings for Haemonetics October 13, 2022 Over the past 3 months, 6 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 October 13, 2022 Upgrades Via Benzinga Haemonetics Stock Near Buy Zone With EPS Due July 27, 2022 With its next earnings report scheduled for around Aug. 10, Haemonetics stock is trading about 10% shy of a 75.44 buy point. Via Investor's Business Daily Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year October 05, 2022 Biotech isn't the only place to make money in health care this year. Via Investor's Business Daily Cutera Stock Earns Relative Strength Rating Upgrade October 03, 2022 On Monday, medical aesthetic Cutera stock had its Relative Strength (RS) Rating upgraded to 90 from 80 a day earlier. Via Investor's Business Daily Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary September 12, 2022 Via Benzinga Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review August 12, 2022 The major indexes continued to advance, despite some key warnings. Via Investor's Business Daily Raymond James Thinks Haemonetics Growth Is 'Underappreciated' July 01, 2022 Via Benzinga Haemonetics: Q4 Earnings Insights May 10, 2022 Haemonetics (NYSE:HAE) reported its Q4 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Haemonetics Surges Closer To A Breakout After Squashing Quarterly Estimates, Raising Guidance August 10, 2022 The blood and plasma supplies provider also raised its sales guidance for the fiscal year. Via Investor's Business Daily InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold August 09, 2022 On Tuesday, InMode stock got a positive adjustment to its Relative Strength (RS) Rating, to 86 from 72 a day earlier. Via Investor's Business Daily ShockWave Medical Stock Scores Rising Price Performance With Jump To 92 RS Rating July 11, 2022 ShockWave Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 81 to 92. Via Investor's Business Daily Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here's What You Need To Know July 01, 2022 Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00. Shares of Haemonetics are trading up 1.46% over the last 24... Via Benzinga 4 Analysts Have This to Say About Haemonetics July 01, 2022 Over the past 3 months, 4 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds June 15, 2022 Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26. Via Benzinga ShockWave Medical Stock Shows Rising Price Performance With Jump To 91 RS Rating June 13, 2022 On Monday, ShockWave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 86 to 91. Via Investor's Business Daily 77 Stocks Moving In Tuesday's Mid-Day Session May 10, 2022 Gainers Via Benzinga 103 Biggest Movers From Yesterday May 11, 2022 Gainers Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
